These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Chronic, combined treatment with desipramine and mianserin: enhanced 5-HT1A receptor function and altered 5-HT1A/5-HT2 receptor interaction in rats. Lund A, Mjellem N. Pharmacol Biochem Behav; 1993 Aug; 45(4):777-83. PubMed ID: 8415816 [Abstract] [Full Text] [Related]
28. Destruction of the nucleus raphe obscurus and potentiation of serotonin-mediated behaviors following administration of the neurotoxin 3-acetylpyridine. Wieland S, Kreider MS, McGonigle P, Lucki I. Brain Res; 1990 Jun 18; 520(1-2):291-302. PubMed ID: 1698505 [Abstract] [Full Text] [Related]
29. Regional analysis of 5-HT1A and 5-HT2 receptors in the fawn-hooded rat. Hulihan-Giblin BA, Park YD, Aulakh CS, Goldman D. Neuropharmacology; 1992 Nov 18; 31(11):1095-9. PubMed ID: 1475019 [Abstract] [Full Text] [Related]
30. 5-HT2 antagonists and minaprine block the 5-HT-induced inhibition of dopamine release from rat brain striatal slices. Muramatsu M, Tamaki-Ohashi J, Usuki C, Araki H, Chaki S, Aihara H. Eur J Pharmacol; 1988 Aug 09; 153(1):89-95. PubMed ID: 2975224 [Abstract] [Full Text] [Related]
31. Characterization of a novel serotonin receptor subtype (5-HT1S) in rat CNS: interaction with a GTP binding protein. Zemlan FP, Schwab EF. J Neurochem; 1991 Dec 09; 57(6):2092-9. PubMed ID: 1834802 [Abstract] [Full Text] [Related]
32. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity. Millan MJ, Bervoets K, Colpaert FC. J Pharmacol Exp Ther; 1991 Mar 09; 256(3):973-82. PubMed ID: 1826033 [Abstract] [Full Text] [Related]
33. Naloxone inhibition of stress-induced daily torpor. Pivorun EB, Tannenbaum MG. Life Sci; 1984 May 28; 34(22):2145-50. PubMed ID: 6727554 [Abstract] [Full Text] [Related]
35. S 14671: a naphtylpiperazine 5-hydroxytryptamine1A agonist of exceptional potency and high efficacy possessing antagonist activity at 5-hydroxytryptamine1C/2 receptors. Millan MJ, Rivet JM, Canton H, Lejeune F, Bervoets K, Brocco M, Gobert A, Lefebvre de Ladonchamps B, Le Marouille-Girardon S, Verriele L. J Pharmacol Exp Ther; 1992 Aug 28; 262(2):451-63. PubMed ID: 1323650 [Abstract] [Full Text] [Related]
38. Alterations in serotonin receptor subtypes in ethanol-dependent rats. Ulrichsen J. Alcohol Alcohol; 1991 Aug 28; 26(5-6):567-73. PubMed ID: 1839497 [Abstract] [Full Text] [Related]
39. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats. Lejeune F, Newman-Tancredi A, Audinot V, Millan MJ. J Pharmacol Exp Ther; 1997 Mar 28; 280(3):1241-9. PubMed ID: 9067310 [Abstract] [Full Text] [Related]
40. Increase in serotonin 5-HT1A receptors in prefrontal and temporal cortices of brains from patients with chronic schizophrenia. Hashimoto T, Nishino N, Nakai H, Tanaka C. Life Sci; 1991 Mar 28; 48(4):355-63. PubMed ID: 1824956 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]